$4.52
+0.01 (+0.22%)
Open$4.65
Previous Close$4.51
Day High$4.66
Day Low$4.45
52W High$80.10
52W Low$2.98
Volume—
Avg Volume17.1K
Market Cap2.68M
P/E Ratio—
EPS$-461.25
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 12.54M | 14.60M | 1.35M |
| Net Income | -178,440,599 | -186,935,792 | 424.2K |
| Profit Margin | -1,422.8% | -1,351.6% | 31.3% |
| EBITDA | -119,263,178 | -131,882,224 | 830.6K |
| Free Cash Flow | — | — | 355.4K |
| Rev Growth | -14.1% | -14.1% | -3.8% |
| Debt/Equity | 0.08 | 0.08 | 1.09 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,164.89 | +1.04% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.47 | -0.19% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $149.50 | +1.79% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.74 | +0.29% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.62 | -0.70% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.33 | -0.10% | 11.5 | 30.15B |